189 related articles for article (PubMed ID: 34396788)
41. Additive effects of acidosis and parathyroid hormone on mouse osteoblastic and osteoclastic function.
Bushinsky DA; Nilsson EL
Am J Physiol; 1995 Dec; 269(6 Pt 1):C1364-70. PubMed ID: 8572164
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of acid-induced bone resorption.
Krieger NS; Frick KK; Bushinsky DA
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):423-36. PubMed ID: 15199293
[TBL] [Abstract][Full Text] [Related]
43. Palmitoylation regulates regulator of G-protein signaling (RGS) 16 function. II. Palmitoylation of a cysteine residue in the RGS box is critical for RGS16 GTPase accelerating activity and regulation of Gi-coupled signalling.
Osterhout JL; Waheed AA; Hiol A; Ward RJ; Davey PC; Nini L; Wang J; Milligan G; Jones TL; Druey KM
J Biol Chem; 2003 May; 278(21):19309-16. PubMed ID: 12642592
[TBL] [Abstract][Full Text] [Related]
44. Dynamic regulation of RGS2 in bone: potential new insights into parathyroid hormone signaling mechanisms.
Miles RR; Sluka JP; Santerre RF; Hale LV; Bloem L; Boguslawski G; Thirunavukkarasu K; Hock JM; Onyia JE
Endocrinology; 2000 Jan; 141(1):28-36. PubMed ID: 10614620
[TBL] [Abstract][Full Text] [Related]
45. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells.
Hendriks-Balk MC; van Loenen PB; Hajji N; Michel MC; Peters SL; Alewijnse AE
Eur J Pharmacol; 2008 Dec; 600(1-3):1-9. PubMed ID: 18854184
[TBL] [Abstract][Full Text] [Related]
46. RGS2: a multifunctional regulator of G-protein signaling.
Kehrl JH; Sinnarajah S
Int J Biochem Cell Biol; 2002 May; 34(5):432-8. PubMed ID: 11906816
[TBL] [Abstract][Full Text] [Related]
47. Acidosis and bone.
Bushinsky DA
Miner Electrolyte Metab; 1994; 20(1-2):40-52. PubMed ID: 8202051
[TBL] [Abstract][Full Text] [Related]
48. Decreased potassium stimulates bone resorption.
Bushinsky DA; Riordon DR; Chan JS; Krieger NS
Am J Physiol; 1997 Jun; 272(6 Pt 2):F774-80. PubMed ID: 9227639
[TBL] [Abstract][Full Text] [Related]
49. RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.
Berthebaud M; Rivière C; Jarrier P; Foudi A; Zhang Y; Compagno D; Galy A; Vainchenker W; Louache F
Blood; 2005 Nov; 106(9):2962-8. PubMed ID: 15998835
[TBL] [Abstract][Full Text] [Related]
50. In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression.
Frick KK; Bushinsky DA
Am J Physiol; 1999 Nov; 277(5):F750-5. PubMed ID: 10564238
[TBL] [Abstract][Full Text] [Related]
51. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast.
Bai XC; Lu D; Liu AL; Zhang ZM; Li XM; Zou ZP; Zeng WS; Cheng BL; Luo SQ
J Biol Chem; 2005 Apr; 280(17):17497-506. PubMed ID: 15731115
[TBL] [Abstract][Full Text] [Related]
52. RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling.
Bernstein LS; Ramineni S; Hague C; Cladman W; Chidiac P; Levey AI; Hepler JR
J Biol Chem; 2004 May; 279(20):21248-56. PubMed ID: 14976183
[TBL] [Abstract][Full Text] [Related]
53. Profile of RGS expression in single rat atrial myocytes.
Doupnik CA; Xu T; Shinaman JM
Biochim Biophys Acta; 2001 Dec; 1522(2):97-107. PubMed ID: 11750060
[TBL] [Abstract][Full Text] [Related]
54. The expression patterns of RGS transcripts in platelets.
Kim SD; Sung HJ; Park SK; Kim TW; Park SC; Kim SK; Cho JY; Rhee MH
Platelets; 2006 Nov; 17(7):493-7. PubMed ID: 17074726
[TBL] [Abstract][Full Text] [Related]
55. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.
Komarova SV; Pereverzev A; Shum JW; Sims SM; Dixon SJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2643-8. PubMed ID: 15695591
[TBL] [Abstract][Full Text] [Related]
56. Metabolic acidosis up-regulates PTH/PTHrP receptors in UMR 106-01 osteoblast-like cells.
Disthabanchong S; Martin KJ; McConkey CL; Gonzalez EA
Kidney Int; 2002 Oct; 62(4):1171-7. PubMed ID: 12234287
[TBL] [Abstract][Full Text] [Related]
57. Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Predicted by Three-Dimensional Missense Tolerance Ratio Analysis.
Montañez-Miranda C; Perszyk RE; Harbin NH; Okalova J; Ramineni S; Traynelis SF; Hepler JR
Mol Pharmacol; 2023 Jan; 103(1):21-37. PubMed ID: 36384958
[TBL] [Abstract][Full Text] [Related]
58. The regulators of G protein signaling RGS16 and RGS18 inhibit protease-activated receptor 2/Gi/o signaling through distinct interactions with Gα in live cells.
Kim K; Lee J; Ghil S
FEBS Lett; 2018 Sep; 592(18):3126-3138. PubMed ID: 30117167
[TBL] [Abstract][Full Text] [Related]
59. Identification of metals from osteoblastic ST-2 cell supernatants as novel OGR1 agonists.
Abe-Ohya R; Ishikawa T; Shiozawa H; Suda K; Nara F
J Recept Signal Transduct Res; 2015; 35(5):485-92. PubMed ID: 26053506
[TBL] [Abstract][Full Text] [Related]
60. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells.
Grant SL; Lassègue B; Griendling KK; Ushio-Fukai M; Lyons PR; Alexander RW
Mol Pharmacol; 2000 Mar; 57(3):460-7. PubMed ID: 10692485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
